Display options
Share it on

J Psychopharmacol. 1995 Jan;9(3):273-80. doi: 10.1177/026988119500900311.

Neurochemical and some related psychopharmacological aspects of Tourette's syndrome: an update.

Journal of psychopharmacology (Oxford, England)

G B Baker, P R Chokka, R A Bornstein

Affiliations

  1. Neurochemical Research Unit, Department of Psychiatry, University of Alberta, Canada.

PMID: 22297768 DOI: 10.1177/026988119500900311

Abstract

Neurochemical investigations of Tourette's syndrome (TS) suggest that the symptoms of this disorder may be the result of an imbalance among several neurotransmitter and/or neuromodulator systems. Neurochemicals which have been studied included: catecholamines; acetylcholine; tryptophan and its metabolites; the amino acids γ-aminobutyric acid (GABA), glutamate, phenylalanine and p-tyrosine; trace amines; opioid peptides; cyclic AMP and androgenic hormones. A suitable animal model of TS would do much to advance our understanding of this disorder, and there are some interesting recent developments in this regard.

Publication Types